DBVT - DBV Technologies S.A.
9.5
0.110 1.158%
Share volume: 93,893
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$9.39
0.11
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | |
| Report Date | 05-07-2024 | 07-30-2024 | 11-06-2024 | 04-30-2025 | |
| Total revenue | 1.407 M | 1.161 M | 1.072 M | 753.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.407 M | 1.161 M | 1.072 M | 753.000 K | |
| -17.48% | -7.67% | -29.76% | |||
| Operating expenses | 29.207 M | 34.017 M | 30.882 M | 27.109 M | |
| Selling general and admin | 7.804 M | 8.643 M | 7.220 M | 5.626 M | |
| Research and development | 21.403 M | 25.374 M | 23.662 M | 21.483 M | |
| Total expenses | 29.964 M | 35.003 M | 31.401 M | 27.370 M | |
| 16.82% | -10.29% | -12.84% | |||
| Operating income | -28.558 M | -33.842 M | -30.328 M | -26.618 M | |
| Ebit | -28.558 M | -33.842 M | -30.328 M | -26.618 M | |
| Pretax income | -27.297 M | -33.116 M | -30.442 M | -27.079 M | |
| 21.32% | -8.07% | -11.05% | |||
| Income tax | 48.000 K | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -27.345 M | -33.116 M | -30.442 M | -27.079 M | |
| -21.10% | 8.07% | 11.05% |
